Search
Showing 1 - 23 of 23 results
Prominent Thoracic Surgeon to Lead New Division of Thoracic Surgery at UCSF
Johannes R. Kratz, MD, has been appointed as the inaugural Chief of UCSF’s Division of Thoracic Surgery, one of the leading, academic robotic thoracic surgery programs in the western United States.Sneaky Senescent Cells That Resist Cancer Treatment Can Provide Druggable Lung Cancer Target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development.UCSF Lung Transplant Program Honored as Best in U.S.
UCSF Health’s Lung Transplant program has been awarded INTERLINK’s 2025 Chairman’s Award for Transplant Excellence as the top-performing lung transplant program in the nation.Inhaling Cannabis May Greatly Increase Your Risk of Lung Disease
A new study in the Journal of General Internal Medicine by researchers at UC San Francisco, found that inhaling marijuana every day is associated with a 44% increased chance of developing asthma.One Gene Variant Is Poised to Cure Devastating COPA Syndrome
Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.UCSF Among First in U.S. to Receive New Pulmonary Care Designation
UCSF has been designated a Bronchiectasis and NTM Care Center, based on the depth and breadth of its services.UCSF Thoracic Surgery Leaders Discuss Diagnostic and Surgical Innovations to Treat Lung Cancer and Lung Diseases
Robotic-assisted surgery at UCSF allows thoracic surgeons to perform intricate procedures with a high level of precision and dexterity, providing optimal patient outcomes.How Targeting Aging Cells Could Improve Lung Disease Treatment
UCSF Researchers Identify Drug Pipeline to Attack Aging Cells in Diseased Lung Tissue.UCSF Health Reaches Lung Transplant Milestone
Surgeons at the UCSF Lung Transplant program have performed over 100 transplants in a 12-month period, making it one of a handful of medical centers in the nation to reach that milestone.Improving Clinical Outcomes for Venous Thromboembolism
Venous thromboembolism (VTE) is serious condition that begins with a blood clot in a vein – often in the lower leg – that makes its way to the lungs, causing a pulmonary embolism with potentially fatal consequences.Unconscious Bias in Patient Care: Harms and Paths to Healing
While physicians intend to treat all their patients with equal respect and compassion, studies show that favoritism and other implicit attitudes can emerge, especially in times of stress, affecting medical decisions and care quality.Better Management of Lung Nodules: Cutting-Edge Diagnostic and Therapeutic Tools
Interventional pulmonologist Diana H. Yu, MD – who performed the first robotic bronchoscopy at UCSF – presents the case for more aggressive lung screening in California and throughout the country, then offers an exciting look at the latest ultrasound and robotic techniques for detecting lesions, assessing risk of malignancy and performing biopsies.Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in RosevilleLung Transplant Candidates: Shining a Light on UCSF’s Evaluation Process
In this short presentation, pulmonologist Jeffrey A. Golden, MD, describes how the specialists of the UCSF Lung Transplant Program work together to ensure their patients are likely to succeed, with a focus on factors that can make or break survival prospects.The COPD Blues: A Guide to Optimizing Outpatient Management
For the 30 million adults in the U.S. with COPD, effective care requires providers to have an up-to-date understanding of treatment options as well as the ability to respond to changes in a patient’s status.UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.UCSF Post-COVID Clinic Treats Long Haulers
UC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry Device
A new home spirometry kit combines a spirometer with a patient engagement platform to collect lung function data and symptoms remotely. This enables UCSF’s Lung Transplant team to remotely track patients with the goal of identifying both symptomatic and asymptomatic changes in lung function that may be the first sign of early chronic rejection.Lung Transplant Program
For nine consecutive years, the UCSF Lung Transplant Program has had significantly higher-than-expected post-surgery survival rates — the only program in the country with this record.